Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBSZ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,496
Award facts
- Contract value 100% obligated
- $13,496.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $13,496.14 delivery order for Zepbound 5 mg/0.5 ml pens on January 5, 2026, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract is funded by the Defense Logistics Agency (DLA), a defense-focused federal procurement entity. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply distribution across military healthcare systems worldwide.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp maintains a comprehensive federal contract portfolio delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Zepbound, a tirzepatide-based diabetes treatment, falls within the company's demonstrated capability to supply diabetes medications and other pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. The competitively awarded contract structure and consistent use of firm fixed pricing across AmerisourceBergen's federal contracts reflect the company's ability to compete in open federal procurement and deliver critical medical supplies to military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FBSZ3?
SPE2DR26FBSZ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FBSZ3 worth?
The government has obligated $13,496 on SPE2DR26FBSZ3.
Is contract SPE2DR26FBSZ3 an order under another contract?
Yes. SPE2DR26FBSZ3 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSZ3 competed?
The extent of competition for SPE2DR26FBSZ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award